510(k) · Cleared
ClearedUltraverse RX Pta Balloon Dilatation Catheter
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Bard Peripheral Vascular, Inc. · LIT Catheter, Angioplasty, Peripheral, Transluminal
Cleared on May 30, 2013 as substantially equivalent to K121856 (C.R. Bard, Inc., 2012) and 1 other predicate after a 34-day review. Its family tree reaches back 3 generations to 2004. 11 later devices descend from it.
- Decided
- May 30, 2013
- Review
- 34 days
- Class
- Class II
- Product code
- LIT
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 3 generations to K042537 (2004). 6 ancestors in all, the oldest K012913 (2001). 11 later devices descend from it, 5 citing it directly.
- Root · 3 generations backK042537 Submarine Plus Percutaneous Transluminal Angioplasty (Pta) Catheter…Invatec Innovative Technologies · 2004
- 2 generations backK072947 Savvy Long and Sleek Peripheral Transluminal Angioplasty (Pta)…ClearStream Technologies, Ltd. · 2008
- 1 generation backK100490 Litepac, Model 682ClearStream Technologies, Ltd. · 2010
- This deviceK131199 Ultraverse RX Pta Balloon Dilatation CatheterBard Peripheral Vascular, Inc. · 2013
- Descendant · cites it directly · 4 of its ownK150865 Metacross RX PTA Balloon Dilitation CatheterKANEKA Corporation · 2015
- Descendant · cites it directly · 3 of its ownK180921 Sapphire II PRO Balloon Dilatation CatheterOrbusneich Medical Trading, Inc. · 2018
- Descendant · 2 generations on · 1 of its ownK152873 Crosstella RX Balloon Dilatation CatheterKANEKA Corporation · 2016
- Descendant · 2 generations on · 0 of its ownK252295 RyureiTerumo Corporation · 2026
- Descendant · 2 generations on · 0 of its ownK211349 Selebrek PTCA Balloon Dilatation CatheterKossel Medtech (Suzhou) Co., Ltd. · 2022
Showing 5 of 11 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 11 · See all- K150865Metacross RX PTA Balloon Dilitation CatheterKANEKA Corporation · 2015 · cites it directly4descendants
- K180921Sapphire II PRO Balloon Dilatation CatheterOrbusneich Medical Trading, Inc. · 2018 · cites it directly3descendants
- K152873Crosstella RX Balloon Dilatation CatheterKANEKA Corporation · 2016 · 2 generations on1descendant
- K252295RyureiTerumo Corporation · 2026 · 2 generations on0descendants
- K211349Selebrek PTCA Balloon Dilatation CatheterKossel Medtech (Suzhou) Co., Ltd. · 2022 · 2 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K042537 | Submarine Plus Percutaneous Transluminal Angioplasty (Pta) Catheter, Model… | Invatec Innovative Technologies | 2004 | — |
| −2 | K072947 | Savvy Long and Sleek Peripheral Transluminal Angioplasty (Pta) Catheters | ClearStream Technologies, Ltd. | 2008 | — |
| −1 | K100490 | Litepac, Model 682 | ClearStream Technologies, Ltd. | 2010 | — |
| 0 (this device) | K131199 | Ultraverse RX Pta Balloon Dilatation Catheter | Bard Peripheral Vascular, Inc. | 2013 | — |
| +1 | K150865 | Metacross RX PTA Balloon Dilitation Catheter | KANEKA Corporation | 2015 | — |
| +1 | K180921 | Sapphire II PRO Balloon Dilatation Catheter | Orbusneich Medical Trading, Inc. | 2018 | — |
| +2 | K152873 | Crosstella RX Balloon Dilatation Catheter | KANEKA Corporation | 2016 | — |
| +2 | K252295 | Ryurei | Terumo Corporation | 2026 | — |
| +2 | K211349 | Selebrek PTCA Balloon Dilatation Catheter | Kossel Medtech (Suzhou) Co., Ltd. | 2022 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2001 | 1 | 0 |
| 2010 | 1 | 0 |
| 2012 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 1 | 0 |
| 2016 | 3 | 0 |
| 2017 | 2 | 0 |
| 2018 | 1 | 0 |
| 2020 | 2 | 0 |
| 2022 | 1 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LIT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LIT device
- #1 K241040 Amethyst HP PTA OTW 0.035 Catheterscore 13.9 · 9 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K121856 | Ultraverse 014 and 018 Pta Balloon Dilatation Catheters Line ExtensionSummary page 1…ssification: Class 11 Classification Panel: Cardiovascular Predicate Device: * Ultraverse 014/018 PTA Balloon Dilatation Catheter (K121856, cleared July 11, 2012) * Clearstreamn LitePAC RX PTA Catheter (K100490, cleared March 16, 2010) Bard P… | 2012 |
| * | K100490 | Litepac, Model 682Summary page 1…ar Predicate Device: * Ultraverse 014/018 PTA Balloon Dilatation Catheter (K121856, cleared July 11, 2012) * Clearstreamn LitePAC RX PTA Catheter (K100490, cleared March 16, 2010) Bard Peripheral Vascular, Inc. =L… | 2010 |
What descends from it? (11)
See all 115 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 9 years and passes through 3 companies; a new generation was cleared every 3.2 years on median.
- None of the 6 ancestors has a recall.
- Of its descendants, K150865 (KANEKA Corporation, 2015) has gone furthest, with 4 descendants of its own.
- 1 other device also cites its predicate K121856.
How does its category compare?
All LIT devicesLIT Catheter, Angioplasty, Peripheral, Transluminal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.
FDA decisions per year · LIT
3in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LIT
90in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LIT
1in 2025
Class I (2 since 2007) Class II/III not classified
Adverse event reports per year · LIT
2,073in 2025
MAUDE reports naming product code LIT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 6 | 64 | 0 | 577 |
| 2008 | 8 | 53 | 0 | 513 |
| 2009 | 7 | 29 | 2 | 623 |
| 2010 | 13 | 78 | 1 | 809 |
| 2011 | 10 | 82 | 0 | 857 |
| 2012 | 19 | 29 | 0 | 1,277 |
| 2013 | 14 | 79 | 2 (2) | 1,242 |
| 2014 | 12 | 90 | 3 | 1,178 |
| 2015 | 19 | 112 | 0 | 1,279 |
| 2016 | 11 | 116 | 1 | 1,529 |
| 2017 | 9 | 57 | 0 | 2,081 |
| 2018 | 6 | 118 | 2 | 2,188 |
| 2019 | 4 | 40 | 3 | 2,405 |
| 2020 | 9 | 125 | 0 | 2,443 |
| 2021 | 4 | 61 | 1 | 2,492 |
| 2022 | 8 | 122 | 0 | 2,155 |
| 2023 | 6 | 167 | 0 | 1,807 |
| 2024 | 6 | 43 | 2 | 1,913 |
| 2025 | 3 | 90 | 1 | 2,073 |
| 2026 | 4 | 205 | 0 | — |
What is it indicated for?
Ultraverse® RX PTA Dilatation Catheter is indicated for use in Percutaneous Transluminal Angioplasty of the renal, femoral, popliteal, infra-popliteal, tibial, and peroneal arteries. This catheter is not for use in coronary arteries.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K131199 · printed Nov 6, 2026
Cite this page
510(k) Report. “K131199: Ultraverse RX Pta Balloon Dilatation Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K131199
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026